Factor | Level | Statisticb | COPD | CB | Emphysema |
---|---|---|---|---|---|
All | All | N | 110 | 105 | 17 |
 |  | F | 2.12 (2.05-2.19) | 1.56 (1.50-1.62) | 3.50 (3.13-3.92) |
 |  | R | 2.35 (2.11-2.63) | 1.63 (1.50-1.78) | 3.52 (2.51-4.94) |
 |  | H, PH | 7.43, < 0.001 | 3.14, < 0.001 | 3.87, < 0.001 |
Sex | Male | n | 44 | 46 | 9 |
 |  | F | 2.80 (2.64-2.97) | 1.63 (1.52-1.76) | 5.12 (4.26-6.15) |
 |  | R | 2.87 (2.35-3.50) | 1.80 (1.57-2.06) | 4.70 (2.66-8.30) |
 | Female | n | 28 | 35 | 4 |
 |  | F | 1.92 (1.78-2.06) | 1.52 (1.40-1.65) | 3.50 (2.36-5.19) |
 |  | R | 2.02 (1.53-1.68) | 1.64 (1.40-1.93) | 3.50 (2.36-5.19) |
 | Combined | n | 38 | 24 | 4 |
 |  | F | 1.83 (1.74-1.92) | 1.54 (1.46-1.63) | 2.68 (2.30-3.12) |
 |  | R | 2.07 (1.83-2.35) | 1.44 (1.22-1.71) | 2.68 (1.58-4.54) |
 | Between levels | PB | < 0.001 | NS | < 0.05 |
Continent | N America | n | 36 | 37 | 9 |
 |  | F | 2.77 (2.61-2.93) | 1.45 (1.32-1.60) | 4.70 (3.97-5.57) |
 |  | R | 2.98 (2.35-3.78) | 1.47 (1.25-1.73) | 3.82 (2.30-6.34) |
 | Europe | n | 50 | 55 | 6 |
 |  | F | 1.81 (1.73-1.89) | 1.57 (1.50-1.65) | 2.71 (2.32-3.17) |
 |  | R | 1.99 (1.76-2.25) | 1.71 (1.51-1.94) | 3.00 (1.70-5.28) |
 | Asia | n | 16 | 7 | 2 |
 |  | F | 2.84 (2.91-3.25) | 1.94 (1.69-2.23) | 3.56 (1.88-6.75) |
 |  | R | 2.79 (2.23-3.48) | 2.17 (1.63-2.88) | 3.56 (1.88-6.75) |
 | Other or multicountry | n | 8 | 6 | 0 |
 |  | F | 1.52 (1.31-1.76) | 1.34 (1.14-1.57) |  |
 |  | R | 1.58 (1.22-2.05) | 1.33 (1.13-1.57) |  |
 | Between levels | PB | < 0.001 | NS | < 0.05 |
Study type | Case-control | n | 11 | 9 | 0 |
 |  | F | 3.38 (2.78-4.10) | 1.65 (1.38-1.98) |  |
 |  | R | 3.45 (2.26-5.28) | 1.87 (1.18-2.96) |  |
 | Prospective | n | 35 | 10 | 4 |
 |  | F | 3.92 (3.60-4.26) | 1.59 (1.40-1.81) | 5.32 (4.36-6.49) |
 |  | R | 2.88 (2.23-3.73) | 1.79 (1.24-2.60) | 2.99 (0.91-9.84) |
 | Cross-sectional | n | 64 | 86 | 13 |
 |  | F | 1.85 (1.78-1.92) | 1.55 (1.49-1.62) | 2.87 (2.50-3.30) |
 |  | R | 1.99 (1.81-2.19) | 1.60 (1.45-1.75) | 3.16 (2.50-4.00) |
 | Between levels | PB | < 0.001 | NS | < 0.01 |
Outcome subtype | Mortality | n | 29 | 2 | 2 |
 |  | F | 4.41 (4.04-4.80) | 3.61 (2.61-4.99) | 6.02 (4.90-7.40) |
 |  | R | 3.55 (2.75-4.57) | 5.57 (1.56-19.92) | 6.56 (3.93-10.94) |
 | Lung function (COPD) or symptoms (CB) | n | 51 | 76 | - |
 |  | F | 1.86 (1.78-1.93) | 1.39 (1.32-1.46) |  |
 |  | R | 1.92 (1.72-2.13) | 1.50 (1.36-1.64) |  |
 | Other | n | 30 | 27 | 15 |
 |  | F | 1.87 (1.74-2.02) | 1.90 (1.78-2.04) | 2.78 (2.43-3.18) |
 |  | R | 2.18 (1.80-2.64) | 1.84 (1.58-2.14) | 2.95 (2.23-3.91) |
 | Between levels | PB | < 0.001 | < 0.001 | < 0.001 |
Smoking product | Any | n | 43 | 53 | 4 |
 |  | F | 1.76 (1.65-1.88) | 1.64 (1.55-1.74) | 2.72 (2.31-3.19) |
 |  | R | 2.09 (1.78-2.45) | 1.67 (1.45-1.93) | 2.72 (2.31-3.19) |
 | Cigarettes (ignoring other products) | n | 59 | 49 | 12 |
 |  | F | 2.07 (1.99-2.15) | 1.46 (1.38-1.54) | 4.42 (3.76-5.18) |
 |  | R | 2.19 (1.94-2.47) | 1.53 (1.38-1.70) | 3.33 (2.17-5.10) |
 | Cigarettes only | n | 8 | 3 | 1 |
 |  | F | 6.79 (5.87-7.86) | 2.80 (2.13-3.67) | 12.50 (3.53-44.27) |
 |  | R | 5.78 (3.81-8.77) | 3.28 (1.84-5.84) | 12.50 (3.53-44.27) |
 | Between levels | PB | < 0.001 | < 0.05 | < 0.1 |
Unexposed basec | Never any product | n | 54 | 65 | 6 |
 |  | F | 2.41 (2.28-2.54) | 1.69 (1.60-1.79) | 3.67 (3.23-4.16) |
 |  | R | 2.60 (2.12-3.17) | 1.75 (1.53-2.01) | 4.70 (2.58-8.53) |
 | Never cigarettes | n | 56 | 40 | 11 |
 |  | F | 1.96 (1.88-2.04) | 1.44 (1.36-1.52) | 2.93 (2.28-3.76) |
 |  | R | 2.15 (1.92-2.42) | 1.50 (1.35-1.66) | 2.99 (1.96-4.56) |
 | Between levels | PB | < 0.05 | < 0.05 | NS |